Akorn To Present At Piper Jaffray 28th Annual Healthcare Conference

LAKE FOREST, Ill., Nov. 16, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Akorn's Chief Financial Officer, Duane Portwood, will present at the Piper Jaffray 28th Annual Healthcare Conference.

Event: Piper Jaffray 28 th Annual Healthcare ConferenceDate: November 29, 2016Time: 8:30 a.m. ETLocation: Lotte New York Palace, New York, NY

The presentation will be webcast live and available on the "Events & Presentations" page in the Investor Relations section of the Company's website at investors.akorn.com.  A replay will be posted on the Akorn website approximately one hour after the live events and will be available for 30 days following the presentations.

About Akorn, Inc.Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. Akorn has manufacturing facilities located in Decatur, Illinois; Somerset, New Jersey; Amityville, New York; Hettlingen, Switzerland and Paonta Sahib, India that manufacture ophthalmic, injectable and specialty sterile and non-sterile pharmaceuticals. Additional information is available on Akorn's website at www.akorn.com.
Investors/Media:Stephanie CarringtonICR, Inc.(646) 277-1282Stephanie.carrington@icrinc.com

Primary Logo

If you liked this article you might like

Teva, Mylan Seen to Stay on M&A Sidelines

Teva, Mylan Seen to Stay on M&A Sidelines

Merger Buzz Drives Akorn to Top of Health Chart in April

Merger Buzz Drives Akorn to Top of Health Chart in April

Why Mylan, Perrigo and Endo Won't Be Playing Spoiler in Akorn-Fresenius Tie Up

Why Mylan, Perrigo and Endo Won't Be Playing Spoiler in Akorn-Fresenius Tie Up

European Stocks High on French Perfume and Trump Bump

European Stocks High on French Perfume and Trump Bump

Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More

Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More